Ari Chaouat1, Laurent Savale2, Christos Chouaid3, Ly Tu4, Benjamin Sztrymf2, Matthieu Canuet5, Bernard Maitre6, Bruno Housset7, Christian Brandt8, Philippe Le Corvoisier9, Emmanuel Weitzenblum5, Saadia Eddahibi4, Serge Adnot2. 1. Service des Maladies Respiratoires et Réanimation Respiratoire, Hôpital de Brabois, Centre Hospitalier Régional Universitaire Nancy, Vandoeuvre-lès-Nancy, France; Département de Pneumologie, Nouvel Hôpital Civil, Centre Hospitalier Régional Universitaire Strasbourg, Strasbourg, France. Electronic address: a.chaouat@chu-nancy.fr. 2. Service de Physiologie Explorations Fonctionnelles, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France; Institut National de la Santé et de la Recherche Médicale U841, Faculté de Médecine de Créteil, Créteil, France. 3. Service de Pneumologie, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France. 4. Institut National de la Santé et de la Recherche Médicale U841, Faculté de Médecine de Créteil, Créteil, France. 5. Département de Pneumologie, Nouvel Hôpital Civil, Centre Hospitalier Régional Universitaire Strasbourg, Strasbourg, France. 6. Institut National de la Santé et de la Recherche Médicale U841, Faculté de Médecine de Créteil, Créteil, France; Service de Pneumologie et de Pathologie Professionnelle, Centre Hospitalier Intercommunal de Créteil, Créteil, France. 7. Service de Pneumologie et de Pathologie Professionnelle, Centre Hospitalier Intercommunal de Créteil, Créteil, France. 8. Centre Hospitalier Régional Universitaire Strasbourg, Hôpital Civil, Centre d'Investigation Clinique, Strasbourg, France. 9. Centre d'Investigation Clinique, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France; Institut National de la Santé et de la Recherche Médicale U841, Faculté de Médecine de Créteil, Créteil, France.
Abstract
BACKGROUND: Pulmonary artery remodeling triggered by alveolar hypoxia is considered the main mechanism of pulmonary hypertension (PH) in COPD patients. We hypothesized that the risk for PH in COPD is increased by an elevation in the proinflammatory cytokines interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), and IL-1beta, as well as by specific genetic polymorphisms of these cytokines. METHODS: We assessed cytokine plasma levels and the polymorphisms G(-174)C IL-6, C(-511)T IL-1beta, and A(-2518)G MCP-1 in 148 COPD patients (recruited at two centers) with right heart catheterization data and 180 control subjects including smokers and nonsmokers. Human pulmonary artery smooth muscle cells (PA-SMCs) were cultured for IL-6 messenger RNA assays under normoxic and hypoxic conditions. RESULTS: Patients with PH (mean pulmonary artery pressure [PAP], >or= 25 mm Hg) had lower Pao(2) and higher plasma IL-6 values than those without PH; there were no differences in terms of pulmonary function test results or CT scan emphysema scores. Plasma IL-6 correlated with mean PAP (r = 0.39; p < 0.001) and was included in a multiple stepwise regression analysis, with mean PAP as the dependent variable. In patients with the IL-6 GG genotype, the mean PAP value was significantly higher and PH was more common than in CG or CC patients (adjusted odds ratio, 4.32; 95% confidence interval, 1.96 to 9.54). Exposure to 4 h of hypoxia led to an about twofold increase in IL-6 messenger RNA in cultured human PA-SMCs. CONCLUSIONS: Inflammation, most likely involving IL-6, may contribute substantially to PH complicating COPD.
BACKGROUND: Pulmonary artery remodeling triggered by alveolar hypoxia is considered the main mechanism of pulmonary hypertension (PH) in COPDpatients. We hypothesized that the risk for PH in COPD is increased by an elevation in the proinflammatory cytokines interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), and IL-1beta, as well as by specific genetic polymorphisms of these cytokines. METHODS: We assessed cytokine plasma levels and the polymorphisms G(-174)C IL-6, C(-511)T IL-1beta, and A(-2518)G MCP-1 in 148 COPDpatients (recruited at two centers) with right heart catheterization data and 180 control subjects including smokers and nonsmokers. Human pulmonary artery smooth muscle cells (PA-SMCs) were cultured for IL-6 messenger RNA assays under normoxic and hypoxic conditions. RESULTS:Patients with PH (mean pulmonary artery pressure [PAP], >or= 25 mm Hg) had lower Pao(2) and higher plasma IL-6 values than those without PH; there were no differences in terms of pulmonary function test results or CT scan emphysema scores. Plasma IL-6 correlated with mean PAP (r = 0.39; p < 0.001) and was included in a multiple stepwise regression analysis, with mean PAP as the dependent variable. In patients with the IL-6 GG genotype, the mean PAP value was significantly higher and PH was more common than in CG or CC patients (adjusted odds ratio, 4.32; 95% confidence interval, 1.96 to 9.54). Exposure to 4 h of hypoxia led to an about twofold increase in IL-6 messenger RNA in cultured humanPA-SMCs. CONCLUSIONS: Inflammation, most likely involving IL-6, may contribute substantially to PH complicating COPD.
Authors: Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi Journal: Hypertension Date: 2010-10-04 Impact factor: 10.190
Authors: Harry Karmouty-Quintana; Hongyan Zhong; Luis Acero; Tingting Weng; Ernestina Melicoff; James D West; Anna Hemnes; Almut Grenz; Holger K Eltzschig; Timothy S Blackwell; Yang Xia; Richard A Johnston; Dewan Zeng; Luiz Belardinelli; Michael R Blackburn Journal: FASEB J Date: 2012-03-13 Impact factor: 5.191
Authors: Alan C-Y Hsu; Kamal Dua; Malcolm R Starkey; Tatt-Jhong Haw; Prema M Nair; Kristy Nichol; Nathan Zammit; Shane T Grey; Katherine J Baines; Paul S Foster; Philip M Hansbro; Peter A Wark Journal: JCI Insight Date: 2017-04-06
Authors: Michael G Risbano; Christina A Meadows; Christopher D Coldren; Tiffany J Jenkins; Michael G Edwards; David Collier; Wendy Huber; Douglas G Mack; Andrew P Fontenot; Mark W Geraci; Todd M Bull Journal: Clin Transl Sci Date: 2010-10 Impact factor: 4.689
Authors: Shiro Mizuno; Laszlo Farkas; Aysar Al Husseini; Daniela Farkas; Jose Gomez-Arroyo; Donatas Kraskauskas; Mark R Nicolls; Carlyne D Cool; Herman J Bogaard; Norbert F Voelkel Journal: Am J Respir Cell Mol Biol Date: 2012-07-27 Impact factor: 6.914